STANDEX REPORTS FISCAL THIRD QUARTER 2025 FINANCIAL RESULTS

Core Viewpoint - Standex International Corporation reported strong financial results for the third quarter of fiscal year 2025, with record sales and operating margins, driven by acquisitions and solid performance in core businesses [1][3]. Financial Performance - Net sales increased to $207.8 million, a 17.2$177.3 million [2]. - Operating income on a GAAP basis rose to $26.3 million, up 20.2$21.8 million [2]. - Adjusted operating income increased to $40.3 million, reflecting a 37.3$21.9 million, a 37.6% increase from $15.9 million [2]. - Diluted EPS on a GAAP basis was$1.81, up 35.4% from $1.35 [2]. Segment Performance - Electronics segment revenue reached$111.3 million, a 38.4% increase year-over-year, with a GAAP operating income of $25.5 million [6][7]. - Engraving segment revenue decreased by 15.7$30.6 million, primarily due to softness in North America [10][17]. - Scientific segment revenue increased by 8.1% to $18.3 million, benefiting from the Custom Biogenic Systems acquisition [12]. - Engineering Technologies segment revenue grew by 36.2$27.4 million, driven by the McStarlite acquisition and organic growth [14]. - Specialty Solutions segment revenue decreased by 13.9% to $20.2 million, reflecting market softness [16]. Strategic Initiatives - The company launched three new products in the third quarter, achieving a total of 13 year-to-date, contributing over 2% to incremental sales [3]. - Standex is focused on managing costs and productivity while investing in strategic growth priorities [3]. - The acquisition of McStarlite is expected to be accretive to earnings in the first year and enhances capabilities in commercial aviation, space, and defense [3]. Outlook - For the fourth quarter of fiscal 2025, the company anticipates slightly to moderately higher revenue and adjusted operating margins, driven by recent acquisitions and pricing initiatives [4][9].